Literature DB >> 8707334

Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers.

W F Pickl1, W Holter, J Stöckl, O Majdic, W Knapp.   

Abstract

HLA class I molecules on activated T cells are expressed as heterodimers associated with beta 2-microglobulin (beta 2-m) and also beta 2-m-free HLA class I alpha-chains. Mechanisms leading to the expression of the activation associated beta 2-m-free HLA class I alpha-chains are poorly defined, however. Upon enzymatical removal of HLA class I alpha-chains on activated T cells, re-expression is observed within minutes upon reculture, reaching half-maximal levels within 1 hr. This process is independent of de novo protein synthesis and of export of newly synthesized proteins. Inhibition of the formation of coated pits by potassium depletion of cells abrogated the re-expression of HLA class I alpha-chains, suggesting that recycling events of HLA class I heterodimers via endosomal compartments are required for the generation of monoclonal antibody LA45-reactive alpha-chains. Furthermore, the rate of alpha-chain generation seems to be governed by the amount of cell surface-expressed HLA class I heterodimers. Taken together these findings suggest that beta 2-m-free HLA class I alpha-chains are generated during the process of class I heterodimer recycling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707334      PMCID: PMC1456465          DOI: 10.1046/j.1365-2567.1996.d01-644.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Internalization of MHC class I molecules is a prerequisite for endocytosis of endorphin by lymphocytes.

Authors:  A M Mommaas; M C Wijsman; W Verduijn; B J Vermeer; F M Claas
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

2.  Peptide binding to empty HLA-B27 molecules of viable human cells.

Authors:  R J Benjamin; J A Madrigal; P Parham
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

3.  Peptide-induced conformational change of the class I heavy chain.

Authors:  T Elliott; V Cerundolo; J Elvin; A Townsend
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

4.  The origin and fate of beta 2m-free MHC class I molecules induced on activated T cells.

Authors:  S Demaria; R Schwab; Y Bushkin
Journal:  Cell Immunol       Date:  1992-06       Impact factor: 4.868

Review 5.  The cell biology of antigen processing and presentation.

Authors:  F M Brodsky; L E Guagliardi
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

6.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments.

Authors:  P A Reid; C Watts
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

7.  Endocytosis and dissociation of class I MHC molecules labeled with fluorescent beta-2 microglobulin.

Authors:  J H Hochman; H Jiang; L Matyus; M Edidin; B Pernis
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

8.  Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression.

Authors:  G R Otten; E Bikoff; R K Ribaudo; S Kozlowski; D H Margulies; R N Germain
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin.

Authors:  E Schnabl; H Stockinger; O Majdic; H Gaugitsch; I J Lindley; D Maurer; A Hajek-Rosenmayr; W Knapp
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.

Authors:  J A Madrigal; M P Belich; R J Benjamin; A M Little; W H Hildebrand; D L Mann; P Parham
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  8 in total

1.  The Authors' Reply.

Authors:  Mepur H Ravindranath; Vadim Jucaud
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  HLA-F complex without peptide binds to MHC class I protein in the open conformer form.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

Review 3.  Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface.

Authors:  Fernando M Ruggiero; Sebastian Springer
Journal:  Curr Res Immunol       Date:  2022-05-23

4.  Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg.

Authors:  M H Ravindranath; P I Terasaki; T Pham; V Jucaud; S Kawakita
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 5.  HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.

Authors:  Mepur H Ravindranath
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

Review 6.  The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling.

Authors:  Kannan Natarajan; Jiansheng Jiang; Nathan A May; Michael G Mage; Lisa F Boyd; Andrew C McShan; Nikolaos G Sgourakis; Ad Bax; David H Margulies
Journal:  Front Immunol       Date:  2018-07-17       Impact factor: 7.561

7.  Many de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers.

Authors:  K Michel; R Santella; J Steers; A Sahajpal; F X Downey; V Thohan; M Oaks
Journal:  HLA       Date:  2016-04-06       Impact factor: 4.513

8.  Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients.

Authors:  Mepur H Ravindranath; Narendranath M Ravindranath; Fatiha El Hilali; Senthamil R Selvan; Edward J Filippone
Journal:  Antibodies (Basel)       Date:  2022-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.